The following funding opportunities are specific to COVID-19. The list will be updated as new opportunities arise.

Sponsor Program Amount (max, if range) Deadline 
National Institutes of Health (NIH) NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB,NCATS Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) Not limited See Emergency Notice of Special Interest by IC
COVID-19 Early Treatment Fund (CETF) Funding for Outpatient Trials Up to $1M Currently accepting applications
Cisco Pandemic/COVID-19 Science, Technology and Social Impact Unspecified  Unspecified 
Autism Speaks COVID-19 Call for Resources N/A Unspecified 
Biogen Foundation (typically funds Boston, MA & Research Triangle,NC) COVID-19 Response Unspecified (up to $10M in total funding) Unspecified (accepting applications)
Draper Richards Kaplan Foundation EWDRK Covid-19 Urgent Response Initiative (CURI) $50,000-$100,000 (CURI invests 25% maximum of total) Unspecified 
Merck KGaA (Germany) Research Grant for Pandemic Preparedness 1,500,000 Euros Applications accepted on a rolling basis
Mozilla COVID-19 Solutions Fund $50,000 Applications accepted on a rolling basis
Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Engagement Awards $150,000 Applications accepted on a rolling basis
Patient-Centered Outcomes Research Institute (PCORI) PCORI Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects $500,000 Applications accepted on a rolling basis
National Institutes of Health (NIH) NINDS Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System $200,000 (direct costs) Applications accepted until 4/14/2021
National Institutes of Health (NIH) NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Budgets should reflect the actual needs Applications accepted until 7/2/2021
National Institutes of Health (NIH)

NIAID

Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Budgets should reflect actual needs (direct costs only) Applications accepted until 7/8/2021
National Institutes of Health (NIH) NIA, NIAID, NIDDK, NIDA, NIMH, NIEHS, NICHD, NIAAA, NIBIB, NHGRI, NIMHD, NCATS, NIDCH, NCI Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement – Clinical Trial Optional) Must reflect your needs Varies by awarding IC
National Institutes of Health (NIH) NIAID Administrative Supplement Not limited 2/6/2020 (applications accepted through 2/6/2021)
National Institutes of Health (NIH) NIGMS Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 Must reflect your needs 3/5/2020 (applications accepted through 2/5/2021)
Department of Energy (DOE) Invitation for COVID-19 Scientific questions DOE Resources 3/18/2020 (reviews start 3/18 but accepted on a rolling basis)
National Institutes of Health (NIH) NIDA Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus $100K direct costs/yr 3/19/2020 (applications accepted through 3/31/2021)
National Institutes of Health (NIH) NIDA  Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Must reflect your needs 3/25/2020 (applications accepted through 3/25/2021)
National Institutes of Health (NIH) NIMH, NIA, NIAAA, NIMHD Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus Contact program officer 3/27/2020 (applications accepted through 4/15/2021)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Check RFA(s) within 4/5/2020 (application deadlines through 4/5/2021)
National Institutes of Health (NIH) NIA, NIMH Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) Must reflect your needs 4/6/2020 (applications accepted through 5/1/2021)
National Institutes of Health (NIH) OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences $200,000 (direct costs) 4/13/2020 (applications accepted until 3/31/2021)
Ferring Pharmaceuticals Ferring COVID-19 Investigational Grants  25,000 Euros 4/15/2020 (applications accepted through 10/31/2020)
National Institutes of Health (NIH) NIBIB Point-of-Care Technology Research Network (POCTRN) Fast-Track Program for COVID-19 Test Development and Distribution) Phase 0: $25,000 Rolling (selection process began 4/29/2020)
National Institutes of Health (NIH) NIAID Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed) $275,000 (direct costs) 4/30/2020 (Applications accepted until 4/30/2021)
National Institutes of Health (NIH) NIAID NEWEmergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed) Budgets must reflect the actual needs 4/30/2020 (Applications accepted until 4/30/2021)
National Institutes of Health (NIH) NHLBI Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials Up to two years of support 5/1/2020 (applications accepted through 10/5/2020)
National Institutes of Health (NIH) NIMHD, NIA, NIMH Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities $125,000 (direct costs) 5/1/2020 (applications accepted through 5/1/2021)
National Institutes of Health (NIH) NIEHS Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) Must reflect your needs 5/1/2020, 6/1/2020 (other deadlines within)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs Budgets must reflect the actual needs 5/4/2020 (applications accepted until 11/10/2020)
National Institutes of Health (NIH) NIAID, NIA Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) Not limited 5/13/2020; 9/13/2020; and others
National Institutes of Health (NIH) NIAAA Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA $200,000 (direct costs) 5/15/2020 (applications accepted until 4/15/2021)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus Limited to amount of current parent 5/15/2020 (applications accepted until 1/25/2022)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus Limited to no more than 25% total costs of the amount of the current parent award 5/15/2020 (applications accepted until 1/25/2022)
National Institutes of Health (NIH) NIDCR Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR $150,000 (direct costs) 6/1/2020 and 11/2/2020
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) Check RFA(s) within 6/5/2020 (other later deadlines within)
National Institutes of Health (NIH) NIMHD, NEI, NHLBI, NIA, NIAAA, NICHD, NIDCR, NIDDK, NIDA, NIEHS,NIMH, NCCIH, NCATS Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations $250,000 (direct costs) 6/10/2020 (applications accepted until 12/15/2020)
National Institutes of Health (NIH) NIMHH, NEI,NHLBI, NIA, NIAAA, NICHD,NIDCD, NIDCR, NIDDK, NIDA, NINR, NIMHD, NCCIH, NCATS Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 $200,000 (direct costs) 6/10/2020 (applications accepted until 12/15/2020)
National Institutes of Health (NIH) NIAID Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Varies (see three FOAs within) 6/16/2020 (subsequent receipt dates through 9/8/2020)
National Institutes of Health (NIH) NIA NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) Must reflect your needs 7/1/2020; 8/3/2020; and others
National Institutes of Health (NIH) OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NINDS, NIMH, NINR, NLM, FIC, NCCIH, NCATS, NCI Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations $700,000 7/8/2020 and 9/8/2020
National Institutes of Health (NIH) OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, FIC, NCCIH, NCATS, NCI Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations $800,000 (direct costs) 7/8/2020 and 9/8/2020
National Institutes of Health (NIH) OD, NHLBI, NHGRI, NIA, NIAID, NIAMS, NICHD, NIDCD, NIDCR, NIDDK, NIEHS, NINDS, NIMHD, NCCIH, NCATS, ORIP, NCI Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project $1,000,000 (direct costs) 7/13/2020; 11/12/2020; other deadlines within
British Society for Antimicrobial Chemotherapy COVID-19 Funding Call $100,000 7/15/2020 (expressions of Interest) ; Full invited applications: 8/31/2020
National Institutes of Health (NIH) NCATS Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)  $9M (direct costs) 8/6/2020 (applications accepted until 1/24/2021)
Genentech 2020 Health Equity Innovations Fund $750,000 8/10/2020 (LOI) ;
Full invited apps: 10/5/2020
National Institutes of Health (NIH) OD, NHLBI, NIA, NIAAA, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NINR, NIMHD, NLM, NCCIH, NCATS, OBSSR Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) $16M (direct costs) 8/25/2020 (JHU internal deadline)
The Greenwall Foundation NEWMaking a Difference Request for Proposals – Fall 2020 $22M 6/24/2020 (LOI) ;
Invited full app: 8/28/2020
Department of Justice (DOJ) NIC FY 2020 COVID 19 – Operational Challenges for Corrections $125,000 8/27/2020
National Institutes of Health (NIH) OD, NIMHD, NIA, NEI, NHLBI, NHGRI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NINDS, NIMH, NINR, NLM, FIC, NCCIH, NCATS, NCI Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) $2.5M (direct costs) 8/28/2020; 12/1/2020
National Institutes of Health (NIH) Common Fund NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional) Must reflect your needs 8/30/2020 (applications accepted through 9/30/2020)
Encephalitis Society Encephalitis and COVID-19 Seed Funding  £10,000 8/31/2020
March of Dimes Request for Applications 2020 COVID-19 Fund $100,000 - $125,000 9/4/2020
National Institutes of Health (NIH) NIAID Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed) $275,000 (direct costs) 9/9/2020
Burdett Trust for Nursing Covid-19: Supporting resilience in the Nursing workforce’ grant programme £20,000 - £100,000 9/12/2020
National Institutes of Health (NIH) NIAID Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2   9/14/2020; 10/14/2020; 11/14/2020 (other deadlines within)
National Institutes of Health (NIH) OD, NIA, NICHD, NIDCD, NIDCR, NINDS, NINR, NLM, ORWH Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional) $750,000 (direct costs) 9/15/2020
National Institutes of Health (NIH) OD, NIDA, NIEHS, NIGMS, NLM Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed) $4,000,000 (direct costs) 9/15/2020
National Institutes of Health (NIH) OD, NIA, NIAAA, NICHD, NCCIH, NCI, NHLBI Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)  $600,000 (direct costs) 9/15/2020
National Institutes of Health (NIH) OD, NIA, NICHD, NIDCD, NIDCR, NINDS, NINR, ORWH Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool $250,000 (direct costs) 9/15/2020
Johnson & Johnson Johnson & Johnson Nurses Innovate QuickFire Challenge in COVID-19 Patient Care $100,000 9/29/2020
Patient-Centered Outcomes Research Institute PCORI) Phased Large Awards in Comparative Effectiveness Research (PLACER) $22M 9/29/2020 (LOI) ;
Full app: 1/12/2021
National Institutes of Health (NIH) OD, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIMHD, FIC Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)  $3,000,000 (direct costs) 9/30/2020
National Institutes of Health (NIH) OD, NIAAA, NIDCR, NIDDK, NIDA, NIGMS, NINR, NIMHD, NLM, OBSSR Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) Must reflect your needs 9/30/2020
U.S. Department of State (DOS) NEWND-NOFO-20-111: COVID-19 Small Grants Program $100,000 9/30/2020
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) CIHPER Grant Programme (2020/2021) $30,000 10/1/2020 (LOI opens) ;
LOI Due: 10/31/2020
National Institutes of Health (NIH) NIDCD Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders Varies (see RFAs within) 10/5/2020 (subsequent receipt dates through 9/8/2022)
National Institutes of Health (NIH) NIMHD, NIA, NIDA, NCI Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) Not limited 10/5/2020 (and standard R01 deadlines)
National Institutes of Health (NIH) NIMHD, NIAMS, NIDA, NIMH, NLM, NCI Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities Must reflect your needs 10/5/2020 (subsequent receipt dates through 5/8/2023)
Biomedical Advanced Research and Development Authority (BARDA) Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Negotiated after white paper stage 10/31/2020 (white paper & full application)
National Institutes of Health (NIH) NCATS Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need Must reflect your needs Applications accepted until 11/10/2020
National Institutes of Health (NIH) NBIB Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need Must reflect your needs Applications accepted until 11/10/2020
National Institutes of Health (NIH) NIDDK Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) $750,000 (direct costs) 12/16/2020
IBSA for Scientific Research The IBSA Foundation Fellowships € 30,000 12/31/2020
Centers for Disease Control (CDC) Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States $2,150,000 1/8/2021
National Science Foundation (NSF) RAPID: Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19) $200,000 Check with program officers